1. Home
  2. BAK vs VOR Comparison

BAK vs VOR Comparison

Compare BAK & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$2.33

Market Cap

900.6M

Sector

Industrials

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$21.19

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAK
VOR
Founded
1972
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
900.6M
1.1B
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
BAK
VOR
Price
$2.33
$21.19
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$4.40
$45.33
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.02
N/A
Revenue Next Year
$7.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$1.62
52 Week High
$5.40
$49.95

Technical Indicators

Market Signals
Indicator
BAK
VOR
Relative Strength Index (RSI) 35.56 61.60
Support Level N/A $11.62
Resistance Level $3.17 $22.22
Average True Range (ATR) 0.15 1.44
MACD 0.03 0.11
Stochastic Oscillator 4.31 82.31

Price Performance

Historical Comparison
BAK
VOR

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: